clinical trials
-
Still Here, November 1: Links and transcript
This week, oral histories from mask bloc organizers are interspersed with some context from journalist and author Britta Shoot, who put together a three-part series collaging said oral histories.
-
Still Here, October 25: Links and transcript
This week, co-hosts Betsy Ladyzhets and Miles Griffis talk with podcast producer James Salanga about an Australian clinical trial looking at low-dose naltrexone for people living with Long COVID and ME.
-
Research updates, October 22
-
Clinical trials explore how Low-Dose Naltrexone could help people with Long COVID
Observational studies suggest Low-Dose Naltrexone may benefit some people with Long COVID and ME. People with these diseases have shared their experiences with LDN in online communities, reflecting the value of patient knowledge. Now, LDN is attracting growing interest from researchers. Current clinical trials include a Long COVID study in Australia, a Spanish study focused…
-
New Long COVID and complex disease center at Mount Sinai set to be a leader in research, clinical care
Last week, a new center serving people with Long COVID and related complex chronic diseases opened at Mount Sinai Health System in New York City. Led by Dr. David Putrino, the center will be a hub for diagnosing these diseases, helping patients manage their symptoms, and running clinical trials of novel treatments. The Cohen Center…
-
Research updates, October 8
-
“A good step”: Long COVID advocates and researchers respond to the RECOVER-Treating Long COVID meeting
Last week, a research symposium in Bethesda, Maryland kicked off RECOVER-Treating Long COVID, a new phase of the National Institutes of Health (NIH)’s flagship research program. The meeting included three days packed with research presentations and panel discussions aiming to advance clinical trials for the disease and capture feedback from people with Long COVID, many…
-
Research updates, September 24
-
Live blog: Following the RECOVER-Treating Long COVID kickoff event
This week, the U.S. National Institutes of Health (NIH) starts a new phase of RECOVER, its flagship, $1.6-billion Long COVID research program. RECOVER has convened leading scientists in a three-day meeting to advance new clinical trials. Following the program’s launch in 2021, RECOVER has drawn criticism for moving slowly and failing to support promising clinical…
-
Research updates, September 10
Research updates for September 10 include a new monoclonal antibody treatment for COVID-19, a new clinical trial for a drug targeting Long COVID neurological symptoms, and research on vaccination and Long COVID.
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance